All Stories

  1. A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice

    Article • OncoImmunology, September 2019, Taylor & Francis

    Dr Jonathan G Pol, Prof. Guido Kroemer

  2. Tumor lysis with LTX-401 creates anticancer immunity

    Article • OncoImmunology, April 2019, Taylor & Francis

    Dr Jonathan G Pol, Prof. Guido Kroemer

  3. Trial watch: dietary interventions for cancer therapy

    Article • OncoImmunology, April 2019, Taylor & Francis

    Dr Jonathan G Pol, FERRERE Gladys, Prof. Guido Kroemer

  4. Anticancer effects of anti-CD47 immunotherapy in vivo

    Article • OncoImmunology, December 2018, Taylor & Francis

    Dr Jonathan G Pol, Prof. Guido Kroemer

  5. Development and applications of oncolytic Maraba virus vaccines

    Article • Oncolytic Virotherapy, November 2018, Dove Medical Press

    Dr Jonathan G Pol, Mathieu Crupi, Kyle Stephenson

  6. Preclinical evaluation of a MAGE-A3 vaccination utilizing the oncolytic Maraba virus currently in first-in-human trials

    Article • OncoImmunology, September 2018, Taylor & Francis

    Dr Sergio A Acuna, Dr Jonathan G Pol, Mathieu Crupi, Dr Brian Lichty, Robin Parsons

  7. Trial watch: peptide-based vaccines in anticancer therapy

    Article • OncoImmunology, September 2018, Taylor & Francis

    Dr Jonathan G Pol, Prof. Guido Kroemer

  8. Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors

    Article • OncoImmunology, August 2018, Taylor & Francis

    Dr Jonathan G Pol, Mathieu Crupi, Prof. Guido Kroemer

  9. Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies

    Article • OncoImmunology, February 2018, Taylor & Francis

    Dr Jonathan G Pol, Prof. Guido Kroemer

  10. Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance

    Article • Cancer Cell, July 2016, Elsevier

    Dr Jonathan G Pol

  11. Trial Watch: Peptide-based anticancer vaccines

    Article • OncoImmunology, January 2015, Taylor & Francis

    Dr Jonathan G Pol

  12. Trial watch: Tumor-targeting monoclonal antibodies for oncological indications

    Article • OncoImmunology, January 2015, Taylor & Francis

    Dr Jonathan G Pol

  13. Trial watch: Dendritic cell-based anticancer therapy

    Article • OncoImmunology, November 2014, Taylor & Francis

    Dr Jonathan G Pol

  14. Trial Watch: Radioimmunotherapy for oncological indications

    Article • OncoImmunology, September 2014, Taylor & Francis

    Dr Jonathan G Pol

  15. Consensus guidelines for the detection of immunogenic cell death

    Article • OncoImmunology, September 2014, Taylor & Francis

    Dr Jonathan G Pol, Abhishek Garg

  16. Trial Watch:

    Article • OncoImmunology, June 2014, Taylor & Francis

    Dr Jonathan G Pol

  17. Maraba Virus as a Potent Oncolytic Vaccine Vector

    Article • February 2014, Elsevier

    Dr Jonathan G Pol

  18. Combining Oncolytic HSV-1 with Immunogenic Cell Death-Inducing Drug Mitoxantrone Breaks Cancer Immune Tolerance and Improves Therapeutic Efficacy

    Article • Cancer Immunology Research, August 2013, American Association for Cancer Research (AACR)

    Dr Jonathan G Pol

  19. Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8+T-cell responses to anticancer vaccines

    Article • OncoImmunology, August 2013, Taylor & Francis

    Dr Jonathan G Pol

  20. Oncolytic viruses: a step into cancer immunotherapy.

    Article • Virus Adaptation and Treatment, December 2011, Taylor & Francis

    Dr Jonathan G Pol, Dr Brian Lichty

  21. Prospective comparison of Abbott RealTime HBV DNA and Versant HBV DNA 3.0 assays for hepatitis B DNA quantitation: Impact on HBV genotype monitoring

    Article • Journal of Virological Methods, December 2008, Elsevier

    Dr Jonathan G Pol

  22. Expression of Defective Hepatitis B Virus Particles Derived from Singly Spliced RNA Is Related to Liver Disease

    Article • The Journal of Infectious Diseases, July 2008, Oxford University Press (OUP)

    Dr Jonathan G Pol

  23. P.053 Spliced hepatitis B virus RNA and liver disease

    Article • Journal of Clinical Virology, January 2006, Elsevier

    Dr Jonathan G Pol